Prosecution Insights
Last updated: October 04, 2026
Application No. 18/722,920

CURABLE RESIN COMPOSITION, CURED FILM, MULTILAYERED OBJECT, IMAGING DEVICE, SEMICONDUCTOR DEVICE, METHOD FOR PRODUCING MULTILAYERED OBJECT, AND METHOD FOR PRODUCING ELEMENT HAVING JUNCTION ELECTRODE

Non-Final OA §102§103
Filed
Jun 21, 2024
Priority
Dec 23, 2021 — JP 2021-209413 +2 more
Examiner
MCCLENDON, SANZA L
Art Unit
Tech Center
Assignee
Sekisui Chemical Co., Ltd.
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1005 granted / 1249 resolved
+20.5% vs TC avg
Moderate +11% lift
Without
With
+10.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
24 currently pending
Career history
1271
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
40.6%
+0.6% vs TC avg
§102
28.2%
-11.8% vs TC avg
§112
18.0%
-22.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1249 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102/35 USC § 103 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-9 and 22 is/are rejected under 35 U.S.C. 102(a1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Matsuo et al (JP56-10379). Matsuo sets forth siloxane-based crosslinkable compositions and films obtained from such. Said crosslinkable compositions comprise (A) a siloxane polymer containing a polysilsesquioxane skeleton represented by formula (1) PNG media_image1.png 279 639 media_image1.png Greyscale and a crosslinkable silicon compound having four or more groups reactive with the hydroxyl group in (A). It is deemed the crosslinkable silicon compound reads/anticipates the heat-resistant silicone resin [claims 1 and 22]—see [0021]- [0025] and examples. Regarding claims 1, 3 and 5-9: Per example 3: Matsuo sets forth a composition comprising (A) a silsesquioxane having the formula PNG media_image2.png 222 507 media_image2.png Greyscale [claim 6-7, wherein n is at least 3 and R; is an alkyl group and R1 is an aromatic group] (B) phenyltrimethoxysilane [claim 22, silicone resin]; and a solvent (toluene: BP 231°C [claim 5])—see [0084]. Said composition is coated onto a coated film and cured under thermal conditions at 80 deg. C for 1 hour and 120 deg. C for 2 hours to obtain a coated film [claim 8]. Mutsuo is silent with regard to the adhesion (JIS K5600-5-6). However, JIS K5600-5-6 measures how strongly the coating sticks/adheres to the substrate and Mutsuo sets forth said coating film is cured, and thus bonded, onto a substrate; thus, the cured film inherently has an adhesion number. However, the Patent and Trademark Office are not equipped to conduct experimentation in order to determine whether Applicant’s composition differs and, if so, to what extent, from the discussed reference. Therefore, with the showing of the reference, the burden of establishing non-obviousness by objective evidence is shifted to the Applicants. In the alternative, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the adhesion number/strength of the composition in order to achieve the desired adhesion number. Matsuo sets forth said cured film has a 5 % weight loss at 395 deg. C [claims 3 and 9]—see [0089]. Regarding claims 2: Matsuo does not expressly set forth the properties, such as tensile modulus of elasticity at room temperature and at 300 deg. C. The tensile modulus of elasticity is the measure of a material's stiffness, or its ability to resist deformation under tensile stress and therefore should be inherent to the cured composition. And since the Patent and Trademark Office is not equipped to conduct experimentation in order to determine whether Applicant’s composition differs and, if so, to what extent, from the discussed reference. Therefore, with the showing of the reference, the burden of establishing non-obviousness by objective evidence is shifted to the Applicants. In this case, one skilled in art prior to the effective filing date of the present invention would know how to alter the modulus of elasticity of the composition in order to achieve the desired stiffness. Regarding claim 3: Matsuo does not set forth the viscosity of the composition; however, said composition is disclosed as a solution in a solvent and therefore should inherently have a viscosity. However, The Patent and Trademark Office is not equipped to conduct experimentation in order to determine whether Applicant’s composition differs and, if so, to what extent, from the discussed reference. Therefore, with the showing of the reference, the burden of establishing non-obviousness by objective evidence is shifted to the Applicants. In the alternative, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in art prior to the effective filing date of the present invention would know how to alter the viscosity of the composition in order to provide a coatable liquid composition in absence of evidence. Allowable Subject Matter Claims 10-21 are objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Matsuo does not expressly set forth the instantly claimed stack structures or methods for producing a stack or element which includes a bonding electrode comprising said resin compositions. Nor does Matsuo set forth imaging devices or semiconductors including said stacks comprising said instantly claimed curable resin. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SANZA L MCCLENDON whose telephone number is (571)272-1074. The examiner can normally be reached 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Riviere-Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SANZA L. McCLENDON/Primary Examiner, Art Unit 1765 SMc
Read full office action

Prosecution Timeline

Jun 21, 2024
Application Filed
Sep 23, 2024
Response after Non-Final Action
Sep 22, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747343
Curable Compositions
3y 7m to grant Granted Sep 29, 2026
Patent 12747305
PHOTOCURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING THREE-DIMENSIONAL OBJECT
3y 4m to grant Granted Sep 29, 2026
Patent 12735584
NEAR-INFRARED CURABLE INK COMPOSITION, NEAR-INFRARED CURED FILM, METHOD FOR PRODUCING NEAR-INFRARED CURED PRODUCT
2y 7m to grant Granted Sep 15, 2026
Patent 12724345
PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE SHEET, CURED FILM, METHOD FOR PRODUCING CURED FILM, ELECTRONIC COMPONENT, ANTENNA ELEMENT, SEMICONDUCTOR PACKAGE, AND DISPLAY DEVICE
3y 11m to grant Granted Sep 01, 2026
Patent 12723109
BIOMASS DERIVED DIKETONES AS EFFICIENT VISIBLE LIGHT PHOTOINITIATORS
3y 9m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
91%
With Interview (+10.7%)
2y 9m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1249 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month